ISRGライブシグナル | Getagraph.comで利益を最大化

買う 3564 min ago

@ $375.32

発行日: 27 4月 2024 @ 04:56

リターン: 0.00%

前回のシグナル: 4月 27 - 01:53

前回のシグナル: 売る

リターン: -0.12 %

Live Chart Being Loaded With Signals

Commentary (27 4月 2024 @ 05:00):

Stats
本日の出来高	927 650
平均出来高	1.53M
時価総額	133.13B
EPS	$1.600 ( 2024-04-18 )
次の収益日	( $1.530 ) 2024-07-18
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	67.63
ATR14	$9.73 (2.59%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-25	Nachtsheim Jami K	Buy	569	Common Stock
2024-04-25	Nachtsheim Jami K	Buy	739	Restricted Stock Units
2024-04-25	Nachtsheim Jami K	Sell	569	Restricted Stock Units
2024-04-25	Kolli Sreelakshmi	Buy	739	Restricted Stock Units
2024-04-25	Kolli Sreelakshmi	Buy	240	Common Stock

INSIDER POWER
-18.58
Last 100 transactions
Buy: 47 446 \| Sell: 69 887

ボリューム相関

長: -0.62 (weak negative)

短: -0.86 (strong negative)

Signal:(28) Be Aware. Possible trading coming up! (swing)

Intuitive Surgical Inc 相関

10 最も正の相関
LWAC	0.87
LIVX	0.863
MMAC	0.862
RAACW	0.861
RAAC	0.856
AMRB	0.841
JCOM	0.832
UPC	0.832
REYN	0.829
EEIQ	0.809

10 最も負の相関
FEYE	-0.886
SVAC	-0.87
DTEA	-0.841
SNPO	-0.836
INZY	-0.834
VTYX	-0.833
INSE	-0.833
TRIN	-0.831
SIBN	-0.83
CVCY	-0.828

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Intuitive Surgical Inc 相関 - 通貨/商品

-0.47
( neutral )

-0.69
( moderate negative )

0.00
( neutral )

-0.70
( moderate negative )

0.21
( neutral )

0.49
( neutral )

Intuitive Surgical Inc 財務諸表

Annual	2023
収益:	$7.12B
総利益:	$4.73B (66.39 %)
EPS:	$5.12

FY	2023
収益:	$7.12B
総利益:	$4.73B (66.39 %)
EPS:	$5.12

FY	2022
収益:	$6.22B
総利益:	$4.20B (67.44 %)
EPS:	$3.72

FY	2021
収益:	$5.71B
総利益:	$3.96B (69.32 %)
EPS:	$4.85

Financial Reports:

No articles found.

Intuitive Surgical Inc

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.